Key result
Abnormal RyR2 phosphorylation linked to heart failure, AF, and ventricular arrhythmias.
Advancing our understanding of RyR2 regulation is critical as it represents a unique and promising therapeutic target for heart failure and arrhythmias.
Answers are grounded in this paper and cite their sources.
RyR2 phosphorylation should not yet guide therapy in HF or arrhythmias; extends CaMKII-S2814 consistency while leaving PKA-S2808 effects open.
Cardiac ryanodine receptor type 2 plays a key role in excitation-contraction coupling. The ryanodine receptor type 2 channel protein is modulated by various post-translational modifications, including phosphorylation by protein kinase A and Ca(2+)/calmodulin protein kinase II. Despite extensive research in this area, the functional effects of ryanodine receptor type 2 phosphorylation remain disputed. In particular, the potential involvement of increased ryanodine receptor type 2 phosphorylation in the pathogenesis of heart failure and arrhythmias remains a controversial area, which is discussed in this review article.
No takes yet. Share an insight, caveat, or question.
Dobrev et al. (2014) conducted a review in Heart failure and arrhythmias. Ryanodine receptor type-2 (RyR2) phosphorylation was evaluated. Abnormal PKA- and CaMKII-dependent phosphorylation of RyR2 may contribute to the pathogenesis of heart failure, atrial fibrillation, and ventricular arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: